Enveda Biosciences secures $55m to advance AI-driven drug discovery

Enveda Biosciences, a leader in utilizing artificial intelligence (AI) to convert nature’s chemistry into groundbreaking medicines, has successfully raised an additional $55 million. This funding ... Read More